R.Y. Lei
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Breast Cancer Treatment Studies 5
-
- Monoclonal and Polyclonal Antibodies Research 2
- Advances in Oncology and Radiotherapy 2
- Co-authors
- Elizabeth M. Jaffee (2 shared papers)Anne M. Ercolini (2 shared papers)R. Todd Reilly (2 shared papers)Jean-Pascal Machiels (2 shared papers)Francesca I. Okoye (2 shared papers)Leisha A. Emens (2 shared papers)Rong Wu (1 shared paper)Denise C. Connolly (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (4 papers)Journal of Surgical Oncology (1 paper)Breast Cancer Research and Treatment (1 paper)Frontiers in Oncology (1 paper)Cancer Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
R.Y. Lei
11 papers receiving 702 citations
Peers
Comparison fields: 5 of 47
- Immunology 409
- Oncology 306
- Cancer Research 81
- Genetics 138
- Radiology, Nuclear Medicine and Imaging 74
Countries citing papers authored by R.Y. Lei
This map shows the geographic impact of R.Y. Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.Y. Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.Y. Lei more than expected).
Fields of papers citing papers by R.Y. Lei
This network shows the impact of papers produced by R.Y. Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.Y. Lei. The network helps show where R.Y. Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside R.Y. Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. | 2001 | 383 |
| 2 | The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors. | 2001 | 128 |
| 3 | Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. | 1997 | 128 |
| 4 | 2013 | 35 | |
| 5 | 2015 | 30 | |
| 6 | 2014 | 9 | |
| 7 | 2021 | 6 | |
| 8 | 2020 | 6 | |
| 9 | 2012 | 1 | |
| 10 | 2011 | 1 | |
| 11 | 2015 | 1 | |
| 12 | 2013 | 1 |
About R.Y. Lei
R.Y. Lei is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 729 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Advanced Radiotherapy Techniques (2 papers), Immunotherapy and Immune Responses (2 papers), Global Cancer Incidence and Screening (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Advances in Oncology and Radiotherapy (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Immunology (409 citations), Oncology (306 citations), Cancer Research (81 citations), Genetics (138 citations) and Radiology, Nuclear Medicine and Imaging (74 citations). R.Y. Lei has collaborated with scholars based in United States. Frequent co-authors include Elizabeth M. Jaffee, Anne M. Ercolini, R. Todd Reilly, Jean-Pascal Machiels, Francesca I. Okoye, Leisha A. Emens, Rong Wu, Denise C. Connolly, Young Tae Kim and Núbia Muñóz. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Surgical Oncology, Breast Cancer Research and Treatment, Frontiers in Oncology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.